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Abstract
Up to one in four patients undergoing prolonged opioid therapy in a primary care setting
battle opioid addiction. In 2020, the CDC found that more than 16,000 deaths involving
prescription opioids (limited to natural and semi-synthetic opioids and methadone) had occurred,
which is equivalent to about 45 deaths per day. Opioid overdose death can be identified through
three distinct waves; increased prescribing of opioids in the 1990’s began the first wave, the
beginning of the second wave came in 2010 with a rapid increase in heroin related overdose
deaths, and in 2013 the third wave began with a significant increase in synthetic opioid related
overdose deaths, specifically fentanyl related which is illicitly manufactured (CDC, 2021).
To better understand how the medical system contributes to opioid misuse and addictions,
a literature review was conducted. The studies showed that many physicians feel like they are
lacking adequate education to prescribe opioids, and often do not do any type of screening for
patients to see if they have struggled with prescription misuse or addiction in the past. After
looking at potential causes and solutions for excessive opioid prescription in the health care
system, it appears that health care providers with more education on opioids prescribed less than
those without. The studies also showed that health care providers with more education in
emergency medicine, and health care providers that implemented patient screenings also
prescribed less opioids overall.
Our goal is to understand how the medical system contributes to prescription opioid
misuse and addiction and what interventions medical professionals can implement to aid in
supporting those with opioid use disorders and addictions. Therefore, based on our Literature
Review findings, a study to examine the issue further is proposed.
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Introduction
In 2020, the total number of opioids prescribed in the United States was 142,816,781.
That is a dispensing rate of 43.3 per 100 persons (Centers for Disease Control and Prevention
[CDC], 2021). With that figure being so high, we couldn't help but wonder if there was a
correlation between the number of people receiving opioid prescriptions and the number of
overdose deaths that occur each year. According to the CDC, during a 12-month period that
ended in April 2021, 75,673 of the 100,306 deaths from overdose were caused by opioids. More
than 564,000 people passed away from opioid overdoses between the years 1990 and 2020,
including both prescription and illicit opioids (CDC, 2021b). Anyone who uses opioids on a
prescription is at risk for addiction. In fact, up to one in four patients undergoing prolonged
opioid therapy in a primary care setting battle opioid addiction. Once dependent, quitting might
be challenging. More than 11.5 million Americans reported abusing prescription opioids in the
previous year, according to data from 2016 (CDC, 2021a). In order to better understand how the
medical system contributes to prescription opioid misuse and addiction, as well as what
interventions can be used by medical professionals to support those who have opioid use
disorders and addictions, the purpose of this study is to demonstrate how the medical system
contributes to these problems.
Problem Statement
In recent years, health care providers have begun raising their concerns about the
healthcare systems contribution to the opioid epidemic. According to the CDC (2021a), primary
care providers are expressing concerns about their insufficient training related to prescribing
opioids, and their fear that patients will become addicted. Opioid death rates have continuously
gone up since the epidemic began in the 1990s, and without proper intervention, the death toll
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and rate of addiction will continue to rise. The problem with prescription opioids and the
contribution to the epidemic varies state by state, seeing a particularly high rise in the Northeast,
Southeast, and Appalachian regions of the US. The opioid epidemic has really taken a toll on
hospitals resources and space as rates of opioid-related visits to the emergency department and
inpatient stays have risen dramatically. Patients fallen victim to prescription opioid use disorder
and individuals suffering with opioid addiction are relying on the healthcare system and its
providers to find a solution by improving the way pain is treated and preventing addiction and
abuse before it begins.
Research Questions
How does the medical system contribute to prescription opioid misuse and addiction, and
what interventions can medical professionals implement to aid in supporting those with opioid
use disorders and addictions?
Relevance
The CDC (2021b) found that more than 16,000 deaths involving prescription opioids
(limited to natural and semi-synthetic opioids and methadone) occurred in 2020, which is
equivalent to about 45 deaths per day. This number is likely an undercount of deaths related to
prescription opioids because it does not include deaths associated with pharmaceutical fentanyl,
tramadol, and other synthetic opioids that are used as pain medications.
Background
Opioid overdose death can be identified through three distinct waves. Increased
prescribing of opioids in the 1990’s began the first wave, with deaths involving overdose of
prescription opioids increasing since at least 1999. The beginning of the second wave came in
2010 with a rapid increase in heroin related overdose deaths. In 2013, the third wave began with
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a significant increase in synthetic opioid related overdose deaths, specifically fentanyl related
which is illicitly manufactured (CDC, 2022).
Literature Review
The objective of this literature review is to understand and identify what impact hospitals
and the medical system have on opioid misuse and addiction, and what interventions medical
professionals can implement to aid those struggling with opioid misuse and addiction. Twelve
research articles are used in this literature review to outline and identify the medical systems
impact on opioid misuse and addiction, as well as what interventions are available to be
implemented. The research articles used in this literature review were found through databases
provided by the Dominican University of California library and include UpToDate, PubMed
Central, CINAHL Plus, and Iceberg. Keywords and terms that were used during the search
include: opioid, opioid misuse, opioid addiction, opioid prescriptions, hospitals and opioids
prescriptions, prescription opioid addiction, prescription opioid misuse, opioid education, and
interventions.
The literature review will be divided into six categories, the first category will include
articles that pertain to opioid prescriptions, misuse, and addictions in adolescents and young
adults. The second category includes articles that show how opioids are used and prescribed
during surgical care. The third category will examine an article that analyzed opioids prescribed
at hospital discharge. The fourth category includes articles relating to health care providers
opioid education and its relatedness to their rates of prescribing. The fifth category includes
articles relating to opioid prescribing policies and guidelines and their effect on rates of opioid
prescribing. The last category includes articles involving potential interventions and solutions to
reduce opioid prescribing. All the articles included in this literature review are very effective in
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describing and analyzing the impact the medical system has on opioid misuse and addiction. See
Appendix A for a Literature Review Table summarizing each research article, including the
strengths and limitations for each study.
Opioid Prescription and Use in Adolescents and Young Adults
The goal of a study conducted by Hudgins, Porter, Monuteaux, and Bourgeois (2019) was
to gather data on prescription opioids in order to assess their incidence and misuse among US
adolescents and young adults as well as identify the sources of these drugs. To determine the
prevalence of opioid use and misuse among adolescents and young adults in the US, the
researchers examined data from an annual cross-sectional survey that gathers information on
prescription opioids. 27,857 adolescents between the ages of 12 and 17 and 28,213 young adults
between the ages of 18 and 25 made up the study that was examined.
Participants were independently questioned about their usage of a list of prescription
opioids during the course of the previous month, year, or lifetime. The researchers then
questioned people further if they gave a positive response or indicated that they had previously
used opioids. The individual was divided into one of three groups using follow-up questions: use
without misuse, misuse without use disorder, or use disorder (Hudgins et al., 2019). The
researchers classified prescription opioid misuse as “use in any way that a doctor did not direct
you to use them”, and they defined an opioid use disorder as “recurrent use which causes
clinically significant impairment, including health problems, disability, and failure to meet major
responsibilities at work, school, or home.” (Hudgins et al., 2019, p. 5). When a participant
reported misuse, they were asked for information about where the opioid was obtained. They
were given the following options: bought or stolen from a stranger or drug dealer; obtained from
one doctor; obtained from more than one doctor; stolen from a medical facility; obtained from
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family or friends (either bought or stolen); or an alternative option was provided if any of the
options did not match how they obtained the opioid (Hudgins et al., 2019).
According to the researchers, out of the sample of young adults and adolescents, 27.5%
had reported that they are using a prescription opioid in the past year and a total of 10.6%
engaged in opioid misuse or having an opioid use disorder. Researchers found that of those that
indicated they had prescription opioid misuse, “25.4% obtained them from the healthcare system,
55.7% from friends or relatives, and 18.9% through other means.” (Hudgins et al., 2019, p. 2).
Researchers also found that those with any type of opioid misuse often have a history of using
other illicit drugs such as cocaine, hallucinogens, and inhalants. The findings of this study reveal
that despite known dangers for developing future opioid and other drug use disorders,
prescription opioid usage among teenagers and young adults in the US remains widespread
(Hudgins et al., 2019). The prevalence of reported prescription opioid usage among young adults
and adolescents, as well as its frequent correlation with other drug and alcohol addiction, help
highlight the significance of screening programs that are needed by healthcare professionals
when prescribing opioids.
In order to determine the patterns of opioid prescribing connected to prescription opioid
overdose in adolescents and young adults, Chua, Brummett, Conti, and Bohnert (2019)
conducted a study. In a quantitative retrospective cohort analysis that was carried out by the
researchers, 2,752,612 patients aged 12 to 21 who had received one or more opioid prescriptions
between July 2009 and October 2017 made up the study's population. (Chua et al., 2019).
Researchers conducted their retrospective cohort study from January 1 to April 30, 2019,
using the 2009-2017 IBM MarketScan Commercial Claims and Encounters database. The
researchers identified all the opioid prescription claims between July 1, 2009, and October 1,
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2017 with the selected age range of 12-21 years old so that they could capture the population
seen by pediatric practitioners (Chua et al., 2019). The study population included “At cohort
entry, the mean age was 17.2 years, 52.8% were female, 84.7% lived in an urban area.” (Chua et
al., 2019, p. 4). The research showed that each increase in daily opioid dosage was associated
with 18% higher odds of overdose (Chua et al., 2019).
The results of this study imply that practitioners may be able to lower the risk of
overdosing adolescents and young adults by using the lowest effective daily dosage, abstaining
from giving opioids and benzodiazepines at the same time, and concentrating on short-acting
opioids (Chua et al., 2019). Finding evidence-based strategies to lower the risk of overdose is
crucial when administering opioids to this population.
Opioids Used During Surgical Care
With preoperative opioid use being so common, there is still little to no evidence to help
guide the prescribing practitioner based on prior opioid use so the study, “Classifying
Preoperative Opioid Use for Surgical Care” by Vu, Cron, Lee, Gunaseelan, Lagisetty, Wixson,
Englesbe, Brummett, and Waljee (2020) was conducted to characterize the patterns of
preoperative opioid use in patients undergoing elective surgery to identify the relationship
between preoperative use and subsequent opioid fill after surgery.
Researchers divided patients who had previously used opioids into groups based on the
prescribed dose, frequency, length of time, and consistency of opioid refills using data from a
national private insurance payer (Vu et al., 2020). Patients aged 18 to 64 who underwent surgery
between January 1, 2008, and March 31, 2015 were included in the study cohort. There were 13
common elective procedures included in the study, including varicose vein removal, laparoscopic
cholecystectomy, laparoscopic appendectomy, hemorrhoidectomy, thyroidectomy, transurethral
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prostate surgery, parathyroidectomy, carpal tunnel release, incisional hernia repair, colectomy,
reflux surgery, bariatric surgery, and hysterectomy (Vu et al., 2020). The researchers had to
define terms in preoperative use and those definitions include: “... identified patients as
preoperative opioid users if they had filled at least one opioid prescription in the year prior to
surgery.” In addition, “Dose was defined as total Oral Morphine Equivalents (OMEs) filled in the
year prior to the operation. Recency was defined as the number of months since the last opioid
fill before the operation. Duration was the total number of months during which a patient filled
an opioid prescription. Continuity was defined as the longest ‘streak’ of months that a patient
consecutively filled a prescription.” (Vu et al., 2020, p. 3).
The study included 267,252 patients who underwent major and minor elective surgical
procedures with 61,173 undergoing a major procedure and 206,079 undergoing a minor
procedure, 68.7% were female, 71.5% were white (Vu et al., 2020). The researchers identified
patterns of preoperative use by creating three different groups which include: minimal use,
intermittent use, and chronic use. Those in the minimal use group were characterized by “... low
dose, <1-month duration use of varying recency. Median (interquartile range [IQR]) prescription
size was 36 pills, and patients received the prescription at a median of 3 months before surgery”,
and there were a total of 73,761 patients in this group (Vu et al., 2020, p. 5). The group of
intermittent use included 12,974 patients and were classified by low dose, remote, short course
use with a median total dose of 129 pills over three months and filled two months prior to
surgery (Vu et al., 2020). The group classified as “chronic use” included 3,337 patients and was
classified as long duration lasting 9-11 months, patients in this group received a median
equivalent of 18,923 pills over a 12-month period which is equivalent to 52 pills per day.
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The study found that 102,748 (38%) of the 267,252 patients filled an opioid prescription
in the year prior to surgery. Three groups of preoperative opioid usage were identified by cluster
analysis, ranging from minimal (27.6%) to intermittent (7.7%) to chronic (2.7%) use (Vu et al.,
2020). Even in patients who only sometimes or infrequently used opioids, preoperative opioid
use was the most significant predictor of second fill, with greater effect sizes than other
variables. In comparison to patients who had never used opioids before, more preoperative use
was linked to a risk-adjusted chance of needing a second opioid fill (Vu et al., 2020). Opioid use
before surgery is widespread among people having elective procedures and even with modest
opioid use, patients are more likely than opioid-naive patients to require extra postoperative
prescriptions in the 30-days after surgery, even though the majority of patients rarely fill pills
prior to surgery (Vu et al., 2020). In the future, detecting preoperative opioid use can influence
how a surgeon prescribes and coordinates care for postoperative pain management.
A quantitative cross-sectional study was carried out by Goel et al. (2020) with the goal of
identifying current patterns of opioid prescription for common surgical procedures, factors
influencing surgeons' prescribing behavior, and surgeons' perceived capability to manage patients
with opioid use disorder.
The participants in this study include staff surgeons and surgical trainees from different
divisions including: general surgery, orthopedic surgery, neurosurgery, thoracic surgery, plastic
surgery, urology, vascular surgery, and cardiac surgery that is associated or conducted with the
University of Toronto as well as the 8 hospitals affiliated with the University of Toronto (Goel et
al., 2020). Goel and the research team (2020) created a survey to get information on the current
prescribing patterns including the type and number of opioids prescribed and the surgeons
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participating in the survey were asked what intervention they have to manage patients with a
history of suspected opioid misuse.
There was a total of 120 responses, eighty were surgical trainees while forty were staff
surgeons and the findings of the survey showed: Five staff surgeons (12%) believed they were
sufficiently knowledgeable to prescribe opioids at discharge and twenty of the thirty-nine staff
surgeons (51%) who suspected an opioid use disorder in their patients said they went looking for
more assistance for them (Goel et al., 2020). These results show that there is a need for
institutional guidelines to help surgical teams in prescribing opioids to their patients and there
needs to be more services available for surgical teams and patients with an opioid use disorder.
Rautalin, Kallio, and Korja (2022) conducted a study, “In-hospital Postoperative Opioid
Use and its Trends in Neurosurgery between 2007 and 2008”, with the objective of investigating
the role that in-hospital large surgical units have on the global opioid crisis. To accomplish this,
researchers performed an extraction and analysis of data of the consumption of opioids in a
neurological ICU and two other bed wards (Rautalin et al., 2022). The neurological ICU
included in this study has 16 beds and the two neurological bed wards have about 50 beds give or
take.
Rautalin et al. (2022) extracted the opioid consumption from the Enterprise resource
Planning (ERP) and all consumption levels were measured by using the defined daily dose, or
DDD. The study included a total of 196,199 treatment days; researchers found that opioid use
was two times higher in the ICU than in the bed wards, oxycodone compromised almost half
(49%) of all used opioids (Rautalin et al., 2022). Over a 12-year period, oral oxycodone use
increased by 375 percent, and transdermal buprenorphine use increased by 930 percent in the bed
wards, because of the rise in strong opioid use in surgical bed wards, the researchers encourage
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other large teaching hospitals and surgical units to look into whether their opioid use trends are
concerning (Rautalin et al., 2022). They also urge them to determine whether the changes in
opioid consumption in the hospital setting are due to changes in opioid use patterns or
opioid-related health problems (Rautalin et al., 2022).
Opioids Prescribed at Hospital Discharge
The goals of the retrospective cohort study conducted by Calcaterra, Yamashita, Min,
Keniston, Frank, and Binswanger (2015) was to measure the risk of chronic opioid usage and
opioid refills among “opioid naïve” patients who received opioids at discharge and those who did
not receive opioids, one year after they were discharged from the hospital.
The researchers examined all surgical and medical discharges between January 1, 2011
and December 31, 2011 from an academic safety net medical center in Denver, Colorado
(Calcaterra et al., 2015). When it was the patient's first discharge, it was noted as the “index
discharge” and those patients were described as “opioid naïve” patients. Patients were labeled as
“opioid recipient” if they filled a prescription within 72 hours of discharge, and the category of
“no opioid receipt” included those that did not fill a prescription following discharge (Calcaterra
et al., 2015).
The results of this study show that "Twenty-five percent of opioid naïve patients had
opioid receipt within 72 hours of discharge. Patients with opioid receipt were more likely to have
diagnoses including neoplasm, acute pain, chronic pain at admission or surgery during their
hospitalization compared to patients without opioid receipt.” (Calcaterra et al., 2015, p. 480).
Patients who received opioids one year after discharge had a higher prevalence of chronic opioid
usage than patients who did not get opioids (Calcaterra et al., 2015). One year after discharge,
receiving an opioid was correlated with higher likelihood of chronic opioid usage and higher
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subsequent opioid refills than not receiving an opioid (Calcaterra et al., 2015). The findings of
this study have shown how important it is for medical professionals to educate their patients on
the risk of consuming and refilling their opioid prescriptions.
Health Care Providers Opioid Education
The following articles examine opioid education within the healthcare system and
evaluate the relationship between opioid education and opioid prescribing by various health care
providers. The first article written by researchers Price, O’Donoghue, Rizzo, Sapru, and Aikin
(July 2021) aimed to assess health care providers exposure to opioid educational information and
its relationship to opioid prescribing practices. The second article written by Leventhal,
Nathanson, and Landry (April 16, 2019) aimed to assess whether differing levels of training and
varying resident specialties among physicians affected their opioid prescribing practices and
prescribing rates. Both research studies were conducted to try and find relationships between
education on opioids and determine whether more education led to decreased prescriptions
among providers, or if more education increased the number of opioid prescriptions written by
providers.
The researchers who wrote “Opioid Education and Prescribing Practices” (Price et al.,
2021), conducted a primary quantitative cross-sectional study using a random sample of 2000
health care providers including primary care physicians, specialists, physician assistants, and
nurse practitioners. The participants from the sample ranged from all types of specialties and
departments. The survey was created to explore exposure to opioid educational information and
opioid prescribing. The sample of participants was randomly created from WebMD’s Medscape
subscriber network and only included health care providers (HCPs) that practiced in office-based
settings and spent at least 50% of time providing patient care. Nurse practitioners and physician
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assistants involved were required to have authority to prescribe in their state, and physicians
were required to be American Medical Association-validated providers. Data measured from this
study included the number of patients given a prescription of opioids for chronic pain, recall of
opioid prescription drug promotions, exposure to opioid educational information, and knowledge
of abuse-deterrent formulation (ADFs). They conducted their analysis to ensure that they
accounted for weighting and sample design effectively.
The results of the study found that primary care physicians prescribed opioids for
significantly more patients with chronic pain compared with other HCPs. They also found that
primary care providers and nurse practitioners reported significantly more exposure to opioid
education than specialists and physician assistants. It seemed that overall, HCPs had a limited
understanding and knowledge of ADFs, however, primary care providers were found to have a
greater knowledge than other health care groups. Analyzing prescription rates within the last
three months compared to the last 12 months, researchers found it to be more likely that health
care providers exposed to more educational opioid information in the last 12 months prescribed
less opioids to patients in the last three months than the prior 12 months if they worked in a state
or county clinic as opposed to a solo or group practice.
Researchers determined from this study that exposure to opioid educational information
may help reduce opioid prescribing for chronic pain among HCPs. The findings of this study
indicated that there is a difference in exposure and knowledge gaps across varying provider
groups and more information is needed on the content of opioid educational information given to
HCPs. Health care providers in this study indicated that continuing education would be the most
helpful resource for supporting safe and effective opioid prescribing.
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The research article, “Variations in Opioid Prescribing Behavior by Physician Training”
(Leventhal et al., 2019), analyzed the researchers qualitative retrospective chart review of
emergency department visits from one tertiary-care academic hospital across one academic year
(2014-2015). Through this chart review, they examined the amount of opioid pain medication
prescribed by comparing morphine milligram equivalents (MME) between level of training of
the provider and provider specialty. They assessed emergency medicine (EM) attending
physicians, emergency medicine residents in training, and non-emergency medicine residents in
training.
The study was conducted to explore how different training levels of physicians and
varying resident specialties prescribe different quantities of opioids. The hospital chosen for the
study is a level one trauma center in an urban area receiving approximately 56,000 visits
annually. All patients discharged from the emergency department (ED) during the study period
had their charts reviewed and those with a prescription for opioid pain medications were
included in the study. The following data was extracted from the electronic medical records:
patient age, gender, triage Emergency Severity Index (ESI), chief complaint, pain score at time
of triage (0-10), and any prescription for an opioid pain medication at time of discharge,
(Leventhal et al., 2019). Prescribing providers were grouped by medical specialty and level of
training, and at the time of the study, there was no opioid prescribing policy meaning these
providers could prescribe using their discretion.
The researchers found that out of 55,999 patient visits, and 32,968 discharges for
outpatient care, 4,431 of those visits included a prescription for an opioid medication (8% of
total visits and 13% of discharged visits) (Leventhal et al., 2019). The median age for these
patients was 45 and the median pain score at time of triage was an eight out of ten. Researchers
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found that the most common chief complaint leading to opioid prescription was “back pain”,
followed by “fall” and “abdominal pain” (Leventhal et al., 2019). Between the three groups
studied (EM attendings, EM residents, and non-EM residents), researchers found that emergency
medicine residents prescribed the least amount of opioids, while non-emergency medicine
residents prescribed the largest amount. The study found that emergency medicine attendings
prescribed less than the non-EM residents, but more than the EM residents (Leventhal et al.,
2019).
From this study, the researchers concluded that physician specialty and level of training
does influence the amount of opioids prescribed from the ED. They were able to determine that
both residents and attendings with emergency medicine training did prescribe less than
non-emergency medicine trained providers, as hypothesized. The researchers believe that a factor
contributing to this is because they were being trained during the current opioid crisis and are
more focused on minimizing opioid prescribing, while attendings were pushed towards treating
discomfort and were taught an emphasis on pain evaluation and reduction during their training
before the opioid epidemic. While there was a significant difference in prescribing behaviors
between groups, overall prescribing of opioids was quite low as seen in this study.
Opioid Prescribing Guidelines and Policies
The following articles examine opioid prescribing guidelines and policies within the
healthcare system and their effects on opioid prescribing by various health care providers.
Researchers Danielson, Harle, Downs, Militello, and Mazurenko (November 2021) wrote the
first article in this study, which aimed to find out how primary care physicians implement opioid
prescribing policies in their treatment decisions and conversations with their patients. The second
article in this study written by Sears, Fulton-Kehoe, Schulman, Hogg-Johnson, and Franklin
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(September 1, 2019) aimed to “determine whether the adoption of state-level opioid prescribing
guidelines that specify a high-dose threshold is associated with trends in rates of opioid overdose
hospitalizations, for prescription opioids, heroin, and all opioids,” (Sears et al., 2019, p. 567).
Both articles explain the use of opioid policies and guidelines and aim to determine whether
these policies increase or decrease opioid prescribing when used by various health care
providers.
The study titled, “How opioid prescribing policies influence primary care clinicians’
treatment decisions and conversations with patients with chronic pain,” (Danielson et al., 2021),
used a secondary qualitative analysis of data from three healthcare systems in the Midwestern
United States involving 64 primary care visits and 87 post visit interviews across 20 clinicians to
find out how opioid policies affect providers treatment decisions. Researchers used recordings
from primary care visits as well as conducted interviews post visit with the primary care provider
in order to understand the decision making of the providers regarding care for their patients with
chronic non-cancer pain. The providers involved in this study had to be authorized to prescribe
opioids and were spread out amongst urban, suburban, and rural clinics in Indiana and Illinois.
Specific excerpts involving the conversation of opioids from the post visit interviews were
selected to be included in the data for the qualitative analysis. The clinicians involved ranged
from having two to 34 years of experience and they varied between being trained medical
doctors, osteopathic physicians, and nurse practitioners.
The results of this study showed three main themes. The first theme was that policies on
opioid prescribing had an influence on clinicians' decisions to not begin opioid treatment and to
use less opioids overall for patients experiencing chronic pain. Clinicians described having a
shift in their mindset after the development of opioid policies and expressed a new concern for
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using opioids to treat pain unnecessarily without trying other pain management options first.
Some clinicians, however, did worry about the new policies causing some patients to be
undertreated and expressed concern for them having negative outcomes due to opioid policies
and guidelines. Another emerging theme was the influence of opioid policies on clinicians’
treatment decisions to taper patients off and discontinue the use of opioid treatments. Many
clinicians felt the new policies influenced their decisions to limit prescriptions, reject patient
requests for increased dosages, consider tapering or discontinuing, and perform regular pill
counts due to the new strict dosage limits. Many clinicians felt that they should initiate
discontinuations and tapering for almost all of their patients in response to the new state laws.
The third theme to emerge was the implementation of clinical precautions directly invoked
during routine care for patients with chronic pain. Clinicians found it very important to discuss
and update opioid contracts, complete risk assessments, explain rationale for routine drug
screenings, and complete prior authorizations following the new guidelines.
From this study, researchers concluded that clinician treatment decisions were influenced
in several ways by opioid prescribing policies, (Danielson et al., 2021). Clinicians began to think
about how they were prescribing, and these policies created a reluctance for initiation of opioids
for almost all patients experiencing chronic pain. Clinicians collectively reduced their
prescribing and began tapering off or discontinuing for a majority of patients, proving that
guidelines on opioids are effective in reducing opioid prescriptions.
The study titled, “Opioid Overdose Hospitalization Trajectories in States With and
Without Opioid-Dosing Guidelines,” (Sears et al., 2019), was a quantitative multiple baseline
difference-in-difference study involving all opioid overdose hospitalizations from three guideline
states in the US compared with five comparator states. Data for this study was based on State
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Inpatient Databases provided by the Healthcare Cost and Utilization Project, Agency for
Healthcare Research and Quality, via HCUPnet (Sears et al., 2019). A negative binomial panel
regression was used to model annual rates trends for opioid overdose hospitalizations. Post
Guideline trends were compared with concurrent trends for comparator states using the
multiple-baseline difference-in-difference study design.
The results of this study found that for each guideline state, there was a significant
decrease in prescription opioid and all opioid overdose hospitalizations post guideline compared
with trends in comparator states. From the study, they found that the mean annual percentage
decrease for trends in rates of prescription opioid overdose hospitalizations ranged from
3.2%-7.5%. They also found that the mean annual percentage decrease for trends in rates of all
opioid overdose hospitalizations ranged from 5.4%-8.5% (Sears et al., 2019).
Sears and the research team (2019), determined that after adoption of opioid prescribing
guidelines, trends in rates of opioid overdose hospitalizations for prescription opioids and for all
opioids significantly decreased in each guideline state compared with the five comparator states.
The data found suggests that there is a net beneficial effect on trends in rates of opioid overdose
hospitalizations in the three guideline states. The study concludes that opioid-prescribing
guidelines can serve as primary prevention by reducing unneeded initial opioid exposure,
secondary prevention by limiting the risks associated with high-dose prescriptions of opioids and
certain concurrent medications, and tertiary prevention by supplying clear guidance for dosage
tapering and treatment of opioid use disorder. Researchers determined that if used properly,
prescribing guidelines may be an important tool for primary prevention of opioid prescription
and opioid overdose hospitalizations (Sears et al., 2019).
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Interventions and Solutions to Reduce Opioid Prescription
The following articles examine effects of non-opioid analgesic options compared to
opioid-based options for care as well as other possible interventions or precautions that can be
taken to reduce the overuse of opioids in medical systems. In the first article in this category,
researchers Hinds, Miller, Maccani, Patino, Kaushal, Rieck, Walker, Brummett, Bicket, and
Waljee (2022) aimed to “explore providers’ current practices and challenges in managing
surgical patients’ opioid-related risks, providers’ views on best practices to reduce patient’s
opioid-related risks, and what additional resources providers identified as necessary,” (Hinds et
al., 2022, p. 476). The second article in this category written by researchers Olausson, Svensson,
Andrell, Jildenstal, Thorn, and Wolf (2022) aimed to evaluate the opioid-based versus
opioid-free anesthesia effects on postoperative adverse events, recovery time, time to discharge
from post-anesthesia care unit, pain, nausea, and vomiting.
The researchers who wrote, “Patient risk screening to improve transitions of care in
surgical opioid prescribing: a qualitative study of provider perspectives,” (Hinds et al., 2022),
conducted a qualitative interview using an interpretive description framework to synthesize
underlying themes from topically coded interview transcripts. The interviews were conducted in
Michigan and included 24 surgery, primary care, and anesthesia providers. They were
interviewed regarding behaviors and attitudes about screening surgical patients to inform
perioperative opioid prescribing in relation to transitions of care, (Hinds et al., 2022). The
participants in this study were sampled specifically based on their expertise and involvement in
perioperative care.
The results of this study showed that providers believed that using multidisciplinary
approaches in a coordinated manner to identify at risk patients related to poor pain and
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opioid-related outcomes could have the potential of improving transitions of care for surgical
opioid prescribing. Surgeons' perceptions on the topic ranged widely, but the study found that
anesthesia and primary care providers saw value in understanding a patient's preoperative risks
related to opioid use. It was found that across specialties, many providers found it ideal to use a
screening tool if used in addition with actionable recommendations, sufficient resources, and
facilitated coordination with other specialties, (Hinds et al., 2022).
From this study, researchers concluded that there is a need for perioperative screening
and postoperative care pathways in the presence of risk factors and the setting of opioid exposure
for pain-related and opioid-related outcomes after surgery (Hinds et al., 2022). This study
determined that there is a need for risk screening of patients before opioid prescribing and that
more research is needed on the topic to understand how much risk screening can be beneficial.
Although it was not part of the initial research question, this study also concluded that an
important practice, which may help reduce poor outcomes related to opioids post-surgery, is to
provide proper education for the patients. In addition, the researchers noted that there is a need
for more pain specialists and improved access to these specialists for patients.
The research study titled, “Total opioid-free general anesthesia can improve postoperative
outcomes after surgery, without evidence of adverse effects on patient safety and pain
management,” (Olausson et al., 2022), is a systematic review and meta-analysis written to assess
opioid-based anesthesia versus opioid-free anesthesia and their effects postoperatively. The
researchers used Pubmed, Embase Cinahl, Cochrane library, and Google Scholar (Olausson et
al., 2022) to conduct their analysis. Included in this paper are randomized control trials published
over a 21-year period. They used studies that compared opioid-based versus opioid-free
anesthesia in adult patients receiving general or regional anesthesia.
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The results of the study showed that there is firm evidence of opioid-free anesthesia
significantly reducing adverse postoperative events in patients undergoing common procedures
such as laparoscopic gynecological surgery, breast surgery, and upper gastrointestinal surgery.
The study showed that mainly, opioid-free anesthesia decreased nausea and vomiting for patients
as compared to the opioid-based options. In addition, opioid consumption postoperatively was
significantly lower in the opioid-free group compared to the opioid using group. However, the
study found no significant difference in the length of stay in the post-anesthesia care unit and
overall pain postoperatively between groups (Olausson et al., 2022).
This study concludes that using opioid-free anesthesia can be successful in reducing
postoperative adverse events and can improve postoperative outcomes in several surgical settings
compared to opioid-based anesthesia. The opioid-free options showed no evidence of adverse
effects on patient safety and pain management. The researchers concluded that opioid-free
analgesic regimens may reduce a variety of postoperative adverse events during the patient's
recovery without increasing the risk for intra- or postoperative complications (Olausson et al.,
2022). These promising findings indicate that there is a need for more research into non-opioid
anesthesia and analgesic options for patients who are at risk for negative patient outcomes due to
opioid use.
Discussion of the Research Literature
To conclude this section of the paper, the articles discussed above all support the idea that
steps can and need to be taken towards reducing opioid prescription rates within healthcare
settings to aid in reducing the opioid epidemic within the US. The literature reveals the daily
consequences that prescription opioids can have on individuals. The amount of opioid analgesics
that medical practitioners have prescribed can be linked to the rise in opioid misuse and
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addiction among young adults. Opioids that are administered to surgical patients frequently are
neither controlled and may not even be necessary. Currently, no routine screening process is in
place to determine which patients would actually benefit from opioids. Additionally, the number
of patients receiving opioids after discharge is rising, and there often is no follow-up to assess if
they are able to reduce their dosage, cut back on how much they take, and eventually wean off
opioids completely.
Potential interventions to reduce opioid prescribing include: offering more education for
health care providers on opioids and proper prescribing behaviors; implementing opioid policies
within healthcare settings; and establishing guidelines within hospitals to better monitor and
potentially limit opioid prescriptions. In addition, use of effective screening tools to identify
patients at risk before prescribing can aid providers in making better individualized treatment
decisions. Screening also might help determine the potential effectiveness of alternative,
non-opioid treatment options for patients who may be opioid naive or at risk for opioid misuse.
After reviewing the literature, a common gap recognized by investigators is the lack of research
on the topic of non-opioid pain management in healthcare systems. There seems to be a major
lack in research on alternative pain management and opioid-free treatment plans as well as
screenings and patient specific care plans for those who may be at a high risk for opioid misuse
and addiction.
Theoretical Framework
Through her contributions to nursing research and nursing education, Kristen Swanson
has had a tremendous impact on patient care, leadership, education, public service, and clinical
practice. A theoretical framework for the nursing care offered at clinical facilities around the
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world is based on her Theory of Caring, which has also served as the basis for hundreds of
scientific studies (Washington State Nurses Association [WSNA}, 2022) .
Swanson's Theory of Caring is founded on the notion that showing patients that nurses
care about them is just as crucial to their wellbeing as the therapeutic services offered. It is the
basis for greater healing and better care since it takes into account and takes care of the full
person (WSNA, 2022). Swanson has contributed significantly to the advancement of research
around caring in nursing through publishing more than 100 publications and book chapters,
giving hundreds of talks, and consulting. Her groundbreaking contributions to the Science of
Caring are improving the quality of nursing care and the results of patient care. Her work has
promoted nursing as a profession for all of us and helped a great number of organizations foster a
pleasant work environment. Swanson's Theory of Caring has given nursing science the direction
it needs to progress and improve the standard of nursing practice across all clinical settings
(WSNA, 2022). Swanson’s Theory of Caring provides an excellent framework for the study,
which is aimed toward improving the standard of care to reduce the occurrence of opioid
addiction.
Proposal For Further Study
While doing our investigation of the literature, we discovered that the research findings
showed physicians and health care providers feel they have less than adequate education on
prescribing opioids leading to uneducated choices of prescribing opioids, many hospitals and
healthcare providers have no type of pre-prescribing screening for patients leading to a potential
contribution to prescription opioid misuse.
Research Question
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Will implementing an opioid risk screening for patients on admission to a general med
surg floor reduce opioid prescribing rates as compared to a hospital in which there is no opioid
risk screening used?
To research this topic, we want to create and implement a screening tool that can be used
by nurses when a patient is admitted to the floor.
Study Design
For our study, we will be conducting a quantitative, experimental, comparative study. We
will be observing participants at two different hospitals within the Sutter Healthcare system in
San Francisco, California, Pacific Medical Center (CPMC) Mission Bernal and CPMC Van Ness.
CPMC Mission Bernal will serve as our control hospital while CPMC Van Ness will be
our experimental hospital.
Ethical Considerations
There are a few ethical considerations to keep in mind to support this research study. To
protect the participants, the study will be reviewed, approved, and closely followed by the
CPMC Internal Review Board (IRB). No recruitment will take place until after IRB approval is
secured. Only patients who are 18-years or older will be eligible to participate. The study will be
explained to all potential participants and for those who choose to participate, written consent
will be obtained. Additionally, participant identification will be kept private throughout the
entirety of the study. In order for the participant to feel comfortable providing the information
that may be needed, strict confidentiality will be crucial. Patients who agree to participate will be
assigned a Study ID and data will be aggregated so that individuals cannot be identified. In
addition, all data that is collected will be maintained on a password protected computer to which
only those on the research team will have access.
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Recruitment
For recruitment for our study, we will ask all patients admitted to the general medical
surgical floor of both hospitals over the span of two months who are receiving pain medication
and pain interventions if they would like to participate. The goal will be to enroll 100
participants (approximately 50 at each hospital) with 50 for the experimental group and 50 for
the control group. The medical-surgical nurses at CPMC Van Ness who admit the patients will be
asked to serve as research assistants for the study and will have the opportunity to attend a
training session to learn how to implement the opioid screening tool for those patients who are
willing to participate. In addition, the primary providers (physicians, nurse practitioners, or
physician assistants) at CPMC Van Ness will be given information about the study, the screening
tool, and pain control methods that could be used as an alternative to an opioid prescription.
All patients at CPMC Mission Bernal who are willing to participate after being provided
with an explanation of the study will proceed with treatment per usual, with no opioid risk
screening tool being used in their treatment plan. The nurses and doctors at CPMC Mission
Bernal will receive information about the study but will not need to participate as research
assistants or receive the training.
Methods
Potential participants from the experimental hospital will be presented with an opioid risk
screening tool during their admission assessment or soon thereafter (see Appendix B for an
example of the screening tool). The participants from the hospital that will serve as the control
will be treated with the usual routine quality care for the condition for which they are
hospitalized, but there will be no specific screening for risk for opioid addiction.
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For the hospital experimental group, the nurses who will be caring for the patients
admitted to the medical surgical units will receive a one-hour training session, scheduled at
convenient times, to learn how to use the screening tool. This screening tool will give the nurse
researchers an idea of how at risk they are for opioid misuse or addiction following their hospital
stay. The results of the screening will be available for the primary provider to review. If a patient
is considered high risk as a result of the screening, their chart will be flagged, and this
information will be included in their care plan along with alternative pain management options to
be considered before opioids are prescribed. These alternative pain management options may
include non-opioid analgesics (Olausson et al, 2022), physical therapy/exercise (Mitchell, 2016),
cognitive behavioral therapy (Lim et al, 2018), mindfulness training (Lachance & McCormack,
2019) and any other non-pharmacological methods the patient may be interested in trying. If a
patient's screening shows a moderate risk, the primary healthcare providers and nurses also can
first try the alternative pain management options, but they may also be started on very low
amounts of opioids for their pain in combination with the alternative options. For a patient who
is very low risk, we may consider prescribing opioids for their pain, if deemed necessary.
One year post discharge, we will reassess all of the same patients from both groups. The
participants will receive a survey to assess how their recovery went. An example of the survey
that will be distributed is seen in Appendix C. This is when we will be able to assess outcomes
for patients who used the screening tool compared to outcomes for the patients who did not use a
screening tool.
From the collected data, we will analyze the information provided by patients who used
the screening tool with patients who did not. We will compare the duration of recovery for each
patient to see if implementing the screening tool had any influence on length of recovery. We
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will analyze the number of patients from each category still on opioid therapy and compare
numbers between hospitals. For patients who discontinued opioid therapy after being prescribed
in the hospital, we will analyze and compare the length of time it took before discontinuing for
each patient. Lastly, we will analyze refills or increased doses of opioid prescriptions for patients
and see if the screening tool had any influence. Using this data, we will do an analysis of overall
wellbeing and determine if there were improved outcomes for patients who received care with
the screening tool versus patients who did not.
When looking at the two different hospitals, after implementing the opioid screening tool,
we hypothesize that there will be a decrease in the prescription of opioids and an increase in
non-opioid pain management in the hospital that implemented the opioid screening tool. The
opioid screening tool will have a big impact on clinical practice since it prioritizes the needs of
the individual patient. Based on each patient's admission score, the nurse can use the opioid
screening tool to give them safe and effective care. Since the results of the opioid screening tool
will be recorded in each patient's chart and accessible during the patient's hospital stay as well as
after discharge, it will also help to maintain continuity of care between members of the care
team.
Conclusion
The health care system is a major contributor to the opioid epidemic. Doctors and other
health care providers do not feel as though they are receiving enough education to make proper
decisions when it comes to treating patients using opioids. HCPs are often over prescribing
which leads to opioid misuse and addictions, or they are under treating pain out of fear of
prescribing too much. Research shows that sufficient education as well as proper resources and
tools for HCPs are effective in reducing opioid prescribing rates, which in turn leads to lower
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risks for misuse and addiction among patients. We hope that the implementation of our in depth
opioid risk screening tool by nurses will positively impact patient care in hospitals and set them
up for success following discharge. If our proposal were to produce the evidence we are hoping
to see, then patients would benefit by having this screening tool implemented by nurses on
admission as a standard of care.
The literature we have presented supports our argument that the healthcare systems lack
of opioid education and resources relating to opioid prescribing is negatively contributing to
opioid misuse and addictions. With the literature provided, we can gain a better understanding of
what the healthcare system is lacking leading to this issue, and what changes we can make to
have a significant improvement in patient care. With our study, we hope to reveal that increased
use of more in-depth opioid risk screening tools will decrease opioid prescriptions contributing
to the opioid epidemic. We hope that implementation of our screening tool will help guide
treatment options and will individualize care plans for each patient as a whole, increasing
positive patient outcomes and decreasing the risks of misuse and addiction paired with opioid
therapy.
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(Articles are listed in the same order as presented in the Literature Review Section)
Authors/Citation

Purpose/Objective
of Study

Sample Population of
interest, sample
size

Study Design

Study Methods

Major Finding(s)

Strengths

Limitations

Hudgins, J. D., Porter,
J. J., Monuteaux, M.
C., & Bourgeois, F. T.
(2019). Prescription
opioid use and misuse
among adolescents
and young adults in
the United States: A
national survey study.
Public Library of
Science (PLoS).
10.1371/journal.pmed.
1002922

The objective of
the study is to
collect information
on prescription
opioids to measure
the prevalence and
misuse among US
adolescents and
young adults as
well as determine
sources of
prescription
opioids.

The study included
27,857 adolescents
from 12-17 years
old and 28,213
young adults 18-25
years old.

Analysis of data from
an annual
cross-sectional survey
that collects
information on
prescription opioids to
measure prevalence of
opioid use and misuse
among US adolescents
and young adults.

The survey includes interviews with
approximately 70,000 individuals
randomly selected annually, using a
multistage area probability sample
for each state and the District of
Columbia. Certain populations,
including younger age groups, are
oversampled to ensure robust
estimates. Interviews are conducted
in the individual’s residence by a
trained interviewer after verbal
informed consent has been obtained.
Data is collected using
computer-assisted personal
interviewing, in which the
interviewer reads a question to the
participant and enters the response
into the computer. For questions on
illicit drug use and other sensitive
behaviors, a more private approach is
used with audio computer-assisted
self-interviewing, enabling
respondents to read or listen to a
question on headphones and enter the
response into the computer
themselves.

Opioid misuse was
reported by 1,050
adolescents and 2,207
young adults. Among
those misusing opioids,
55.7% obtained them from
friends or relatives, 25.4%
from the healthcare
system, and 18.9%
through other means

Strengths of this
study include
their large
sample size and
high rate of
response.

Researchers
reported that
potential limitations
of this study
include, “...that we
cannot exclude
selection bias in the
study design or
socially desirable
reporting among
participants, and
that longitudinal
data are not
available for
long-term follow-up
of individuals.”.

Chua KP,
Brummett CM,
Conti RM,
Bohnert A.
Association of
Opioid
Prescribing
Patterns With
Prescription
Opioid Overdose
in Adolescents
and Young

The purpose of the
study is to identify
opioid prescribing
patterns associated
with prescription
opioid overdose in
adolescence and
young adults.

Study population
included
adolescents and
young adults aged
12-21. There were a
total of 2,752,612
patients aged 12-21
years with 1 or
more opioid
prescription
between July 2009
to October 2017.

A quantitative
retrospective cohort
study

A retrospective cohort analysis
utilizing the IBM Marketscan
Commercial Claims and Encounters
database, a national sample of claims
from non-elderly patients with
private employer-sponsored coverage
throughout the United States, from
2009 to 2017. Large self-insured
firms make up the majority of data
suppliers. A list of national drug
codes found by searching the IBM
Market Scan Red Book to identify

The findings suggest that
by utilizing the lowest
effective daily dosage,
refraining from
administering opioids and
benzodiazepines
simultaneously, and
focusing on short-acting
opioids, practitioners may
be able to reduce the risk
of overdosing adolescents
and young adults. It is
essential to identify

Strengths
include the use
of a large
national data set
and a sample
size of more
than 3 million
person-days of
opioid
exposure.

Limitations include;
that they did not
examine harms of
prescription opioid
exposure other than
overdose; database
lacked data on
race/ethnicity and
any information on
prescribers; they
likely failed to
capture all
overdoses
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Purpose/Objective
of Study

Sample Population of
interest, sample
size

Study Design

Adults. JAMA
Pediatr. 2020 Feb
1;174(2):141-148.
doi:
10.1001/jamapedi
atrics.2019.4878.
PMID: 31841589;
PMCID:
PMC6990690.

Study Methods

Major Finding(s)

prescription claims for opioids and
benzodiazepines.

evidence-based measures
to reduce the risk of
overdose when prescribing
opioids to this population
if we are to avoid
prescription opioid
overdose in adolescents
and young adults.

Strengths

Limitations

potentially resulting
in underestimation
of overdose risk
associated with
prescribing
patterns; they could
not differentiate
between intentional
or unintentional
overdose

Vu, J., Cron, D., Lee,
J., Gunaseelan, V.,
Lagisetty, P., Wixson,
M., Englesbe, M.,
Brummett, C., &
Waljee, J. (2020).
Classifying
Preoperative Opioid
Use for Surgical
Care. Annals of
Surgery, 271(6),
1080-1086.
10.1097/SLA.0000000
000003109

To characterize the
patterns of
preoperative opioid
use in patients
undergoing elective
surgery to identify
the relationship
between
preoperative use
and subsequent
opioid fill after
surgery

Patients aged 18-64
years of age
undergoing major
or minor surgeries
between
2008-2015. A total
of 267,252 patients
were included in the
study.

Quantitative research
and analysis of data
from DataMart
Database

An analysis of claims data from
DataMart Database for patients aged
18-64 years of age undergoing major
or minor surgeries between
2008-2015. Preoperative use was
defined as any opioid prescription
filled a year before surgery. A cluster
analysis was done to group patients
by the dose, duration, recency, and
continuity of use.

Out of 267,252 patients,
102,748 filled an opioid
prescription in the 12
months before surgery.
Cluster analysis yielded 6
groups of preoperative
opioid use, ranging from
minimal to intermittent to
chronic use. Preoperative
opioid use was the most
influential predictor of
second fill. Even with
modest opioid use,
patients are more likely
than opioid-naive patients
to require extra
postoperative prescriptions
in the 30-days after
surgery, even though the
majority of patients rarely
fill pills prior to surgery. In
the future, recognizing
preoperative opioid use
can assist surgeons in
prescribing and
coordinating therapy for
postoperative pain control

Strengths of this
study include its
large sample
size and
long-term study.

Limitations of this
study include;
limited patient
sample, not
sampling adults
enrolled in
Medicare and
Medicaid, and does
not account for
opioid use outside
of prescription

Goel, A., Feinberg, A.,
McGuiness, B., Brar,
S., Srikandarajah, S.,
Pearsall, E., McLeod,

The objectives of
this study were to
determine current
opioid-prescribing

All staff surgeons
and surgical
trainees from the
divisions of general

A quantitative
cross-sectional survey
study

Survey participants included all
consultant and trainee surgeons at the
University of Toronto. The survey,
which was administered

Five staff surgeons (12%)
felt adequately educated to
prescribe pain medications
(including opioids) at

The survey is a
reliable method
of inquiry
because surveys

Limitations of the
study include a low
response rate, with
limited responses
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R., & Clarke, H.
(2020). Postoperative
opioid-prescribing
patterns among
surgeons and
residents at
university affiliated
hospitals: a survey
study. Canadian
Journal of Surgery,
63(1), E1-E8.
10.1503/cjs.016518

patterns for
common surgical
procedures, factors
that affect
surgeons’
prescribing
behavior and their
perceived ability to
manage patients
with opioid use
disorder

surgery, orthopedic
surgery,
neurosurgery,
thoracic surgery,
plastic surgery,
urology, vascular
surgery and cardiac
surgery associated
with the University
of Toronto and its 8
affiliated hospitals
were invited to
participate in this
study. In total, 120
faculty members
responded to the
survey.

Rautalin, I., Kallio,
M., & Korja, M.
(2022). In-hospital
postoperative opioid
use and its trends in
neurosurgery between
2007 and 2018.
Springer Science and
Business Media LLC.
10.1007/s00701-021-0
5021-9

The objective of
this study is to
investigate the role
that in-hospital
large surgical units
have on the global
opioid crisis.

Opioid
consumption in the
neurological ICU
and wards between
2007-2018 on
treatment days.
There were 196,199
treatment days of
which 75.9%
occurred in bed
wards and 24.1% in
the ICU

Study Design

Extraction and
analysis of data of
consumed opioids in
the neurological ICU
and two bed wards.

Study Methods

Major Finding(s)

Strengths

Limitations

electronically, included 52
multiple-choice, rank-order and
open-text questions eliciting
information on current prescribing
patterns, prescribing of adjunct pain
medications, and education and other
factors related to opioid prescribing.
Staff surgeons were also asked about
how they manage patients with a
suspected opioid issue

discharge. Staff surgeons
prescribed Tylenol 3 more
frequently than other
opioids. Twenty (51%) of
39 staff surgeons reported
that they sought further
help for their patients
when an opioid use
disorder was suspected

are standardized
in that the same
questions,
phrased in
exactly the
same way for
each participant

from attending
surgeons

Data was extracted of consumed
opioids in the neurological intensive
care unit and two bed wards between
2007 and 2018. Data that was
analyzed includes overall
consumption, trends for the weak and
strong, and the most commonly used
opioids. The use of opioids was
standardized by using the defined
daily doses of each opioid agent. A
linear regression analysis was
performed to estimate annual
treatment day adjusted changes.

Overall, 121,361 opioid
DDDs were consumed
during the 196,199
treatment days.
Oxycodone was the most
commonly used
postoperative opioid in
neurosurgery. In the bed
wards, the use of oral
oxycodone increased
375%, and the use of
transdermal buprenorphine
930% over the 12-year
period. Due to the increase
of strong opioid use in the
surgical bed wards, this
study encourages other
large teaching hospitals
and surgical units to
investigate whether their
opioid use trends are
similarly worrisome and
whether the opioid
consumption changes in
the hospital setting are
transferred to opioid use

The study
received ethics
approval from
the institutional
review board of
Helinski
University
Hospital

The study did not
have access to
patient-level data
therefore could not
investigate whether
the opioid
consumption links
to a specific patient
group or to a certain
type.
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The two groups
of the study
were well
defined.

Limitation of this
study include being
unable to capture
patients who filled
opioid prescriptions
at non-affiliated
pharmacies

patterns or opioid-related
harms after discharge

Calcaterra, S. L.,
Yamashita, T. E., Min,
S., Keniston, A.,
Frank, J. W., &
Binswanger, I. A.
(2015). Opioid
Prescribing at
Hospital Discharge
Contributes to
Chronic Opioid Use.
Springer Science and
Business Media LLC.
10.1007/s11606-015-3
539-4

This study aimed to
characterize opioid
prescribing at
hospital discharge
among ‘opioid
naïve’ patients.
Opioid naïve
patients had not
filled an opioid
prescription at an
affiliated pharmacy
1 year preceding
their hospital
discharge. This
study also set out to
quantify the risk of
chronic opioid use
and opioid refills 1
year post discharge
among opioid naïve
patients with and
without opioid
receipt at discharge

The population of
interest included
6,689 opioid
participants from 1
January 2011 to 31
December 2011.

A retrospective cohort
study

This study examined all patients
discharged during 2011. The
discharging physician may have been
a medical or surgical resident
physician, or a hospitalist. The first
discharge for each patient was
categorized as the ‘index discharge.’
Patients were categorized into the
‘opioid receipt’ cohort if they filled
an opioid prescription at a Denver
Health-affiliated pharmacy within 72
hours of their index discharge. They
were categorized into the ‘no opioid
receipt’ cohort if they did not fill an
opioid prescription following
discharge.

Twenty-five percent of
opioid naïve patients had
opioid receipt within 72
hours of discharge.
Patients with opioid
receipt were more likely to
have diagnoses including
neoplasm, acute pain,
chronic pain at admission,
or surgery during their
hospitalization compared
to patients without opioid
receipt. Chronic opioid use
1 year post discharge was
more common among
patients with opioid
receipt compared to
patients without opioid
receipt. Opioid receipt was
associated with increased
odds of chronic opioid use
and greater subsequent
opioid refills 1 year post
discharge compared to no
opioid receipt

40

Authors/Citation

Sample Population of
interest, sample
size

Purpose/Objectiv
e of Study

Study Design

Study Methods

Major Finding(s)

Strengths

Limitations

Price, S. M.,
;Donoghue, A. C.,
Rizzo, L., Sapru,
S., & Aikin, K. J.
(2021). Opioid
Education and
Prescribing
Practices. Journal
of the American
Board of Family
Medicine, 34(4),
802-807.
10.3122/jabfm.20
21.04.200610

A random sample
of 2000 health
care providers was
used including
primary care
physicians,
specialists,
physician
assistants, and
nurse
practitioners. The
participants
ranged from all
types of
specialties and
departments.

The purpose of
this study was to
assess health care
providers
exposure to opioid
educational
information and
its relationship to
opioid prescribing
practices

Primary
quantitative
cross-sectional
study

Surveys were sent
out to a random
selection of health
care providers to
assess knowledge,
attitudes, and
practices in
multiple domains,
including
prescription drug
promotions,
clinical trials,
FDA policies, and
opioids.

Primary care
physicians were
found to have
prescribed opioids
for significantly
more patients with
chronic pain
compared with
other health care
providers. Primary
care providers and
nurse practitioners
reported
significantly more
exposure to opioid
education than
specialists and
physician
assistants. The
study finds that
exposure to opioid
educational
information may
help reduce opioid
prescribing.

This study
provides national
estimates for
HCP’s exposure to
opioid educational
information
making it an
important research
study.

Study response
rates were low,
and the study
results are limited
to self-reported
data. This gives it
the potential to
have social
desirability bias.
HCP may
underreport the
number of patients
prescribed opioids
or may over-report
exposure to
education on
opioids.

Leventhal, E. L.,
Nathanson, L. A.,
& Landry, A. M.
(2019). Variations
in Opioid
Prescribing
Behavior by

Patients
discharged from
the ED with a
prescription for
opioid pain
medications. This
included all

The purpose was
to assess whether
differing levels of
training and
varying resident
specialties among
physicians

Qualitative

Patient age,
gender, triage
emergency
severity index,
chief complaint,
pain score at time
of triage, and any

Non-emergency
medicine residents
prescribed more
opioids than
emergency
medicine trained
providers. This

Small but
statistically
significant
variations in
opioid prescribing
practices between
providers of

The study was
limited to a single,
tertiary, academic
medical center and
its generalizability
to other
institutions must

Retrospective
chart review
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Physician
Training. Western
Journal of
Emergency
Medicine.
10.5811/westjem.2
019.3.39311

patients seen in a
single academic
year in a single,
urban, academic
Level 1 trauma
center which gets
approximately
56,000 annual
visits.

affected their
opioid prescribing
practices and
prescribing rates.

Danielson, E. C.,
Harle, C. A.,
Downs, S. M.,
Militello, L., &
Mazurenko, O.
(2021). How
opioid prescribing
policies influence
primary care
clinicians'

The sample used
was adult primary
care providers
authorized to
prescribe opioids.
Providers were
recruited from
urban, suburban,
and rural clinics
spanning three

The purpose of
this study was to
find out how
primary care
physicians
implement opioid
prescribing
policies in their
treatment
decisions and

Study Design

A secondary
qualitative
analysis of data
from 64 primary
care visits and 87
post visit
interviews across
20 clinicians from
3 healthcare
systems in the

Study Methods

Major Finding(s)

Strengths

Limitations

prescription for an
opioid pain
medication at the
time of discharge
was digitally
extracted from
electronic medical
records.
Prescribing
providers were
grouped based on
medical specialty
and level of
training.

study shows that
physician
specialty and level
of training
influence the
amount of opioids
prescribed from
the ED.

different levels of
training and
specialty were
noted. This study
is important
because it shows
evidence that there
is a link between
education levels of
opioids and the
level of
prescribing.

be carefully
considered. Since
this is a
retrospective
analysis,
unmeasured
confounders may
have biased the
analysis. Only the
final discharge
prescription was
evaluated, and
they were unable
to measure the
effect of any
discussion held
between the
resident trainee
and the attending.
They were also
unable to measure
any changes in the
planned
prescribing
amount prior to
the patient’s
discharge.

Used interview
data and primary
care clinic visit
recordings
collected as part of
a larger study to
understand
decision making
of primary care
providers when

1. Opioid
prescribing
policies influenced
clinicians'
decisions to not
initiate opioids
and use less
opioids overall for
patients with
chronic pain.

Midwestern US
has been
particularly
affected by the
opioid overdose
crisis and as a
result, is an
important place to
study.

Since the study is
a secondary
analysis of data
collected for
related-research
questions, it is
acknowledged that
the results may not
be a
comprehensive
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treatment
decisions and
conversations with
patients with
chronic pain.
Journal of Opioid
Management,
17(6), 499-509.
10.5055/jom.2021.
0684

health care
systems in Indiana
and Illinois.

conversations with
their patients.

Midwestern
United States.

caring for patients
with chronic
non-cancer pain.
Data was collected
from regularly
scheduled primary
care visits
between provider
and patient, which
were audio
recorded.
Post-visit
interviews were
conducted with
the provider
involved in each
recorded patient
visit.

2. Opioid
prescribing
policies influenced
clinician's
treatment
decisions to
initiate opioid
tapering and
discontinuation.
3. Clinical
precautions,
described in the
opioid prescribing
policies, were
directly invoked
during routine
care for patients
with chronic pain.

Strengths

Limitations

representation of
policy related
decision making
or policy related
conversations with
patients with
chronic pain.
Findings may not
be generalizable to
other settings, as
this study took
place in the
Midwestern US.
Findings may be
affected by
selection bias of
individuals who
were willing and
able to participate
in the provider
interviews and
clinic visits. A
single clinical visit
was captured
rather than the
ongoing
patient-clinician
relationship,
which could have
made it possible
other instances of
treatment
decisions and
conversations
related to
opioid-prescribing
policies were
missed.
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Sears, J. M.,
Fulton-Kehoe, D.,
Schulman, B. A.,
Hogg-Johnson, S.,
& Franklin, G. M.
(2019). Opioid
Overdose
Hospitalization
Trajectories in
States With and
Without
Opioid-Dosing
Guidelines. Public
Health Reports
(1974), 134(5),
567-576.
10.1177/00333549
19864362

All opioid
overdose
hospitalizations
from 3 guideline
states compared
with 5 comparator
states

The objective of
this study was to
determine whether
the adoption of
state-level opioid
prescribing
guidelines that
specify a
high-dose
threshold is
associated with
trends in rates of
opioid overdose
hospitalizations,
for prescription
opioids, for
heroin, and for all
opioids.

Quantitative
multiple-baseline
difference-in-diffe
rence study

3 guideline states
and 5 comparator
states were
identified.
States-level opioid
overdose
hospitalization
data from
2001-2014 was
collected from
these 8 states. A
negative binomial
panel progression
was used to model
trends in annual
rates of opioid
overdose
hospitalizations.

Opioid-dosing
guidelines may be
an effective
strategy for
combating the
public health crisis
of the opioid
epidemic because
it can serve as
primary
prevention by
reducing initial
exposure,
secondary
prevention by
minimizing risks
associated with
high-dose opioid
prescribing, and
tertiary prevention
by providing clear
guidance for
dosage tampering
and treatment of
opioid use
disorder.

This study is the
first to assess
state-level
opioid-dosing
guidelines using
comparator states
to control for
secular trends
related to national
guidelines. The
multiple baseline
approach allowed
the researchers to
demonstrate
repeated patterns
of association
between policy
intervention and
outcome which
adds to the weight
of evidence that
the policy
intervention had
an effect.
Generalizability of
the study was
enhanced since the
study included 8
states representing
various
geographical
regions and more
than a quarter of
the US population.

Using hospital
discharge data, the
researchers
captured a large
share of
opioid-related
morbidity but not
the full scope.
Trends in rates of
opioid overdose
hospitalizations
are known to vary
substantially by
region. The
observational
study also could
not rule out other
casual factors,
including national,
state, and local
opioid-related
interventions.
Opioid-prescribin
g guidelines may
have a varying
effect based on
being voluntary or
enforceable or
based on their
source.

Hinds, S., Miller,
J., Maccani, M.,
Patino, S.,

24 surgery,
primary care, and
anesthesia

This study aims to
explore providers’
current practices

Qualitative
interview study
using an

Qualitative
interviews were
conducted

Providers believed
that coordinated,
multidisciplinary

This analysis is
important because
it will inform the

The majority of
participants work
in a single, large,
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Kaushal, S.,
Rieck, H., Walker,
M., Brummett, C.
M., Bicket, M. C.,
& Waljee, J. F.
(2022). Patient
risk screening to
improve
transitions of care
in surgical opioid
prescribing: a
qualitative study
of provider
perspectives.
BMJ.
10.1136/rapm-202
1-103304

providers in
Michigan.

and challenges in
managing surgical
patients’
opioid-related
risks, providers’
views on best
practices to reduce
patient’s
opioid-related
risks, and what
additional
resources
providers
identified as
necessary.

interpretive
description
framework

regarding
behaviors and
attitudes about
screening surgical
patients to inform
perioperative
opioid prescribing
in relation to
transitions of care.

approaches to
identify patients at
risk of poor pain
and opioid-related
outcomes could
improve
transitions of care
for surgical opioid
prescribing.
Across specialties,
most providers
favored a
screening tool if
coupled with
actionable
recommendations,
sufficient
resources, and
facilitated
coordination
between
specialties.

development of a
perioperative
transition of care
pathway, which
could pave the
way for additional
models in
identifying other
chronic patient
conditions leading
to increased
surgical quality
and patient safety.

academic
healthcare system
and therefore the
generalizability of
findings beyond
this setting is
uncertain. The
sample size was
limited, both per
specialty and
overall. Two of the
four primary care
providers
commonly treat
opioids-exposed
chronic pain
patients which
may cause their
perspective to not
be representative
of the majority of
primary care
providers. Due to
multiple
interviewers,
certain interview
questions lacking
precision, and
audio recording
failures, data was
not always
consistent and
complete and may
have introduced
unknown biases
and errors.
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Olausson, A.,
Svensson, C. J.,
Andréll, P.,
Jildenstål, P.,
Thörn, S., & Wolf,
A. (2022). Total
opioid‐free
general anesthesia
can improve
postoperative
outcomes after
surgery, without
evidence of
adverse effects on
patient safety and
pain management:
A systematic
review and
meta‐analysis.
Wiley.
10.1111/aas.13994

1934 patients from
26 RCTs
Adult patients (
>18 years old)
undergoing
general or regional
anesthesia.

The purpose was
to evaluate the
opioid-based
versus opioid-free
anesthesia effects
on postoperative
adverse events,
recovery time,
time to discharge
from
post-anesthesia
care unit, pain,
nausea and
vomiting.

Systematic review
and meta-analysis

Researchers
searched PubMed,
Embase, Cinahl,
Cochrane Library,
selected reference
lists, and Google
Scholar. We
included
randomized
controlled trials
(RCTs) published
between January
2000 and February
2021 with at least
one opioid- free
study arm, i.e. no
opioids
administered
preoperatively,
during anesthesia
induction, before
skin closure, or
before emergence
from anesthesia.

There is firm
evidence that
opioid- free
anesthesia
significantly
reduced adverse
postoperative
events (OR 0.32,
95% CI 0.22 to
0.46, I 2 = 56%, p
< 0.00001),
mainly driven by
decreased nausea
(OR 0.27, (0.17 to
0.42), p <
0.00001) and
vomiting (OR 0.22
(0.11 to 0.41), p <
0.00001).
Postoperative
opioid
consumption was
significantly lower
in the opioid- free
group (−6.00 mg
(−8.52 to −3.48), p
< 0.00001). There
was no significant
difference in
length of postanesthesia care
unit stay and
overall
postoperative pain
between groups.

This is the first
meta- analysis
comparing
completely opioidfree general
anesthesia with
opioid- based
general anesthesia.
This study
highlights
important gaps in
research for opioid
and opioid-free
related research.

This review only
included
publications in
English to avoid
inaccurately
analyzing studies
in other languages.
Although opioidfree regional
anesthetic
techniques could
be effective in
several settings,
17 we only found
one study that
assessed opioidfree alternatives
for regional
anesthesia, 5 0 and
a subgroup
analysis was
therefore not
feasible.
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Appendix B
Screening Tool to be Implemented on Admission
Questions to ask on admission:

Circle scoring based on answers given on admission

How long is the expected stay?

1 = < 3 days
2 = 4 - 7 days
3 = > 7 days

What is the severity of the patient’s condition?

1 = Recovering from routine procedure
2 = Acute condition
3 = Chronic disease
4 = Traumatic/severe condition

Has the patient been on opioid therapy before?

0 = No
1 = Yes

Does the patient have a history of addiction or substance
abuse?

0 = No
1 = Yes, alcohol
2 = Yes, prescription drugs
3 = Yes, illegal drugs
4 = Yes, any type of opioid

Does the patient have a family history of addiction?

0 = No
1 = Yes, alcohol
2 = Yes, prescription drugs
3 = Yes, illegal drugs
4 = Yes, any type of opioid

Does the patient have a support system such as family or
friends?

0 = At bedside and involved in care
1 = Not at bedside but involved in care
2 = Not at bedside, not involved in care

Does the patient have any diagnoses of any
psychological/mental illnesses?

0 = No
1 = Yes

Does the patient have any of the following risk factors
Poverty
Unemployment
Being female
Young age (<46)
History of criminal activity or legal problems including
DUIs
Regular contact with high-risk people or high-risk
environments
Problems with past employers, family members and
friends (mental disorder)
Risk-taking or thrill-seeking behavior
Heavy tobacco use
History of severe depression or anxiety
Stressful circumstances
Prior drug or alcohol rehabilitation

0 = None
1 = Poverty
1 = Unemployment
1 = Female sex
1 = Age <46
1 = History of criminal activity or legal problems including DUIs
1 = Regular contact with high-risk people or high-risk
environments
1 = Problems with past employers, family members and friends
(mental disorder)
1 = Risk-taking or thrill-seeking behavior
1 = Heavy tobacco use
1 = History of severe depression or anxiety
1 = Stressful circumstances

Total: / 30

Total of 0-10: Minimal Risk
Total of 10-20: Moderate Risk
Total of 20-30 : Severe Risk
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Appendix C
To conduct this study, there will be a link to the Opioid Research Survey with an explanation of
the study and a statement advising potential research participants of their rights, information
about consent, and contact information for the researchers.
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For permission to reproduce or use this survey, contact the authors.

